Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Journal of Virology|November 27, 2015
Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in HumansMaria Fernanda de Castro-Amarante, Cynthia A Pise-Masison, Katherine McKinnon, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2015
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120Matthew J Blackburn, Ma Zhong-Min, Francesca Caccuri, et al.Vaccine|October 16, 2007
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251)Qifeng Zhou, Rachmat Hidajat, Bo Peng, et al.Journal of the American College of Surgeons|January 21, 2014
Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndromeAllison B Weisbrod, Mio Kitano, Francine Thomas, et al.The Journal of Clinical Investigation|May 20, 2014
Vaccine-induced myeloid cell population dampens protective immunity to SIVYongjun Sui, Alison Hogg, Yichuan Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Phase I trial of a new schedule of romidepsin in patients with advanced cancersLaleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, et al.Virology|February 7, 2008
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaquesL Jean Patterson, Jennifer Beal, Thorsten Demberg, et al.British Journal of Haematology|August 1, 2012
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent diseaseTwalib Ngoma, Melissa Adde, Muheez Durosinmi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infectionValentina Cecchinato, Elzbieta Tryniszewska, Zhong Min Ma, et al.Journal of Experimental & Clinical Cancer Research : CR|July 16, 2010
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenibLokesh Jain, Tristan M Sissung, Romano Danesi, et al.Pageof 13